Morgan Stanley Maintains Overweight on Globe Life, Lowers Price Target to $197

Benzinga Newsdesk www.benzinga.com Negative 79.1%

Neg 79.1% Neu 0% Pos 0%

Morgan Stanley analyst Bob Huang maintains Globe Life (NYSE:GL) with a Overweight and lowers the price target from $208 to $197.